BioLineRx (BLRX) Net Margin (2018 - 2026)
BioLineRx (BLRX) recorded Net Margin of -1475.85% in the quarter ended Jun 30, 2026, down 179.80 percentage points from -1296.05% a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Net Margin (2018 - 2026) Analysis & Trends
On a TTM basis, BioLineRx's Net Margin came in at -878.34% as of Jun 30, 2026, down 853.74 percentage points year-over-year; for the year ended Dec 31, 2025, it was -171.69%, down 139.83 percentage points from the prior year.
- Across earlier years, Net Margin came in at -31.86% in the year ended Dec 31, 2024 (+1230.93 pp) and -1262.79% in the year ended Dec 31, 2023.
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Net Margin in data going back to the quarter ended Mar 31, 2024.
- On a year-over-year basis, Net Margin rose in 1 of the last five quarters, with an average year-over-year change of -204.66 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.06 Bn | 1,102.65 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 367.24 Bn | 321.62 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.48 Bn | 235.17 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | -1.65% |
| 10 | BioLineRx | 8.67 Mn | -67.85 Mn | 235,000.00 | -1,475.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,475.85% |
| Dec 31, 2025 | -1,152.58% |
| Sep 30, 2025 | -228.81% |
| Jun 30, 2025 | -1,296.05% |
| Mar 31, 2025 | 2,010.59% |
| Dec 31, 2024 | -27.13% |
| Sep 30, 2024 | -117.78% |
| Jun 30, 2024 | 8.97% |
| Mar 31, 2024 | -10.15% |
| Sep 30, 2021 | -1,732.12% |
| Mar 31, 2021 | -2,600.00% |
| Sep 30, 2020 | -726.10% |
| Mar 31, 2020 | -1,450.87% |
| Sep 30, 2019 | -482.01% |
| Mar 31, 2019 | -1,024.13% |
| Sep 30, 2018 | -57,490.91% |
API Access
BioLineRx Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();